Cargando…
TTMV-RARA fusion as a recurrent cause of AML with APL characteristics
Autores principales: | Sala-Torra, Olga, Beppu, Lan W., Abukar, Faduma A., Radich, Jerald P., Yeung, Cecilia C. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631554/ https://www.ncbi.nlm.nih.gov/pubmed/35420676 http://dx.doi.org/10.1182/bloodadvances.2022007256 |
Ejemplares similares
-
Rapid detection of myeloid neoplasm fusions using single-molecule long-read sequencing
por: Sala-Torra, Olga, et al.
Publicado: (2023) -
Uncoupling RARA transcriptional activation and degradation clarifies the bases for APL response to therapies
por: Ablain, Julien, et al.
Publicado: (2013) -
Adefovir dipivoxil inhibits APL progression through degradation of the oncoprotein PML-RARA
por: Gong, Xubo, et al.
Publicado: (2022) -
A graphical, interactive and GPU-enabled workflow to process long-read sequencing data
por: Reddy, Shishir, et al.
Publicado: (2021) -
ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype
por: Lucena-Araujo, Antonio R., et al.
Publicado: (2016)